Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc. is a registered legal entity registered in United States under 5501069, and its current status with California Secretary of State — bizfile Online is active. The company was incorporated on 9 February 2023 and lists its registered address as United States. 1 shareholder is on record for Endonovo Therapeutics, Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 21 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
One shareholder is currently on record for Endonovo Therapeutics, Inc., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Family Cfo Inc , holding 0.3% — the largest recorded stake.
Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Family Cfo Inc | 0.3% | California Secretary of State — bizfile Online |
Officers
5
The Chairman & Ceo of Endonovo Therapeutics, Inc. currently on record is Alan Collier; five officers are currently on record for Endonovo Therapeutics, Inc., filed with California Secretary of State — bizfile Online.
Management authority at Endonovo Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Endonovo Therapeutics, Inc.?
One shareholder is currently on record for Endonovo Therapeutics, Inc., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Family Cfo Inc , holding 0.3% — the largest recorded stake. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Endonovo Therapeutics, Inc.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Endonovo Therapeutics, Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Endonovo Therapeutics, Inc. have on record?
1 shareholder is shown on record for Endonovo Therapeutics, Inc..
What is Endonovo Therapeutics, Inc.'s company registration number?
Endonovo Therapeutics, Inc.'s registration number is 5501069, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.
Is Endonovo Therapeutics, Inc. still an active company?
Endonovo Therapeutics, Inc.'s status on California Secretary of State — bizfile Online is listed as active.
When was Endonovo Therapeutics, Inc. incorporated?
Endonovo Therapeutics, Inc. was incorporated on 9 February 2023, according to California Secretary of State — bizfile Online.
What is Endonovo Therapeutics, Inc.'s registered address?
The registered address on file for Endonovo Therapeutics, Inc. is United States.
Who are the officers/directors of Endonovo Therapeutics, Inc.?
The Chairman & Ceo of Endonovo Therapeutics, Inc. currently on record is Alan Collier; five officers are currently on record for Endonovo Therapeutics, Inc., filed with California Secretary of State — bizfile Online. Management authority at Endonovo Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to Endonovo Therapeutics, Inc.'s ownership over time?
This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to Endonovo Therapeutics, Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Endonovo Therapeutics, Inc.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like Endonovo Therapeutics, Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 21 October 2026.